Klinik fanlar yilnomasi Том 2 № 4 (2025)

CHRONIC HEART FAILURE TODAY: A LITERATURE REVIEW

Эргашов Бобир Баходирович

Читать на сайте источника PDF

Аннотация

The article focuses on the current classification of CHF by left ventricular ejection fraction (HFrEF, HFmrEF, HFpEF) and NYHA functional classes. Current approaches to diagnostics, including the use of biomarkers and imaging methods, are covered. Current drug treatment strategies, including the use of RAAS inhibitors, beta-blockers, aldosterone antagonists, and SGLT2 inhibitors, are considered in detail. New areas of therapy and five-year mortality data are also presented. The article includes tables and diagrams illustrating the epidemiological and clinical aspects of CHF. The review emphasizes the need for a multidisciplinary approach and further research in the field of personalized therapy.

chronic heart failure, ejection fraction, pathogenesis, treatment, diagnostics, SGLT2, ACE inhibitors, mortality.хроническая сердечная недостаточность, фракция выброса, патогенез, лечение, диагностика, SGLT2, ИАПФ, смертность.surunkali yurak yetishmovchiligi, qon otib berish fraksiyasi, patogenezi, davolash, tashxislash, SGLT2, AAFI, o‘lim.

Источник метаданных: OAI-PMH архив журнала · Sindex не хранит полный текст, а даёт ссылку на источник.

Цитировать

APA 7
Эргашов Бобир Баходирович (2025). CHRONIC HEART FAILURE TODAY: A LITERATURE REVIEW. Klinik fanlar yilnomasi, 2(4).
GOST R 7.0.5
Эргашов Бобир Баходирович CHRONIC HEART FAILURE TODAY: A LITERATURE REVIEW // Klinik fanlar yilnomasi. 2025. Т. 2. № 4.
BibTeX
@article{баходирович2025,
  author  = {Эргашов Бобир Баходирович},
  title   = {CHRONIC HEART FAILURE TODAY: A LITERATURE REVIEW},
  journal = {Klinik fanlar yilnomasi},
  year    = {2025},
  volume  = {2},
  number  = {4}
}
RIS
TY  - JOUR
AU  - Эргашов Бобир Баходирович
TI  - CHRONIC HEART FAILURE TODAY: A LITERATURE REVIEW
JO  - Klinik fanlar yilnomasi
PY  - 2025
VL  - 2
IS  - 4
ER  -